BioNexus Gene Lab Corp (NASDAQ: BGLC) Stock Information | RedChip

BioNexus Gene Lab Corp (NASDAQ: BGLC)


$0.2310
-0.0315 ( +6.45% ) 4.0M

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Market Data


Open


$0.2310

Previous close


$0.2625

Volume


4.0M

Market cap


$3.83M

Day range


$0.2020 - $0.4070

52 week range


$0.2020 - $3.3900

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 68 May 15, 2024
8-k 8K-related 15 May 09, 2024
8-k 8K-related 17 Apr 18, 2024
10-k Annual reports 84 Apr 16, 2024
8-k 8K-related 15 Apr 01, 2024
nt Quarterly Reports 1 Mar 28, 2024
10-q/a Quarterly Reports 65 Mar 26, 2024
def Proxies and info statements 1 Feb 29, 2024
pre Proxies and info statements 1 Jan 26, 2024

Latest News